Related Experiment Video
Updated: Jul 17, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Peri-operative tobacco cessation interventions: a systematic review and meta-analysis
S Harrogate1,2, J Barnes2, K Thomas3
1Elizabeth Blackwell Institute, University of Bristol, Bristol, UK.
Peri-operative tobacco cessation interventions significantly increase successful smoking abstinence at the time of surgery and 12 months post-surgery. These interventions help reduce complications and improve patient outcomes.
Area of Science:
- Medical Research
- Public Health
- Surgical Oncology
Background:
- Tobacco smoking substantially elevates the risk of postoperative complications.
- The peri-operative period presents a critical window for smoking cessation interventions to mitigate risks and enhance long-term health.
- Evidence for the efficacy of tobacco cessation interventions in surgical patients requires systematic review.
Approach:
- Conducted a systematic review of randomized controlled trials (RCTs) focusing on peri-operative tobacco cessation.
- Performed a random-effects meta-analysis to synthesize abstinence outcomes at surgery and 12 months post-surgery.
- Analyzed 38 studies (7310 participants) and included 26 studies (5969 participants) in the meta-analysis, with subgroup analyses based on intervention timing and intensity.
Key Points:
- Peri-operative interventions demonstrated increased successful abstinence at surgery (RR 1.48, NNT 7) and at 12 months post-surgery (RR 1.62, NNT 9).
- The quality of evidence was judged as moderate due to heterogeneity and high risk of bias in included studies.
- Interventions were effective regardless of timing or intensity, suggesting broad applicability.
Conclusions:
- Peri-operative tobacco cessation interventions are effective in improving smoking abstinence rates.
- Further research is needed to optimize intervention design, delivery, and integration into surgical pathways.
- Standardized outcome measures are recommended for future clinical trials in this area.
More Related Videos
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
CNS Depressants: Alcohol and Nicotine
Acute Coronary Syndrome IV: Interprofessional Care
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment